Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ADH1B | P00325 | 1/20 | 0.38 |
| ▸ | ADH1C | P00326 | 1/20 | 0.38 |
| ▸ | ADH1A | P07327 | 1/20 | 0.38 |
| ▸ | ADH4 | P08319 | 1/20 | 0.38 |
| ▸ | ADH7 | P40394 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.35 |
| ▸ | FDPS | P14324 | 3/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL349368 | 1.00 | OPRM1 (0.42) | OPRM1SPHK1LMNADNM1TSHR | |
| SCHEMBL2836084 | 1.00 | OPRM1 (0.42) | OPRM1SPHK1LMNADNM1TSHR | |
| SCHEMBL8141589 | 1.00 | OPRM1 (0.42) | OPRM1SPHK1LMNADNM1TSHR | |
| SCHEMBL2871557 | 1.00 | OPRM1 (0.42) | OPRM1SPHK1LMNADNM1TSHR | |
| SCHEMBL1171909 | 1.00 | OPRM1 (0.42) | OPRM1SPHK1LMNADNM1TSHR | |
| SCHEMBL413280 | 1.00 | OPRM1 (0.42) | OPRM1SPHK1LMNADNM1TSHR | |
| Bromide SCHEMBL5089312 | 0.98 | OPRM1 (0.41) | OPRM1SPHK1LMNADNM1TSHR | |
| Iodide SCHEMBL5086753 | 0.98 | OPRM1 (0.41) | OPRM1SPHK1LMNADNM1TSHR | |
| Hydrochloric Acid SCHEMBL5085417 | 0.98 | OPRM1 (0.41) | OPRM1SPHK1LMNADNM1TSHR | |
| Iodide SCHEMBL5138687 | 0.98 | OPRM1 (0.41) | OPRM1SPHK1LMNADNM1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3040421-B1 | METHOD FOR MEASURING CHOLESTEROL IN HIGH-DENSITY LIPOPROTEIN, AND REAGENT FOR USE IN SAID METHOD | SEKISUI MEDICAL CO LTD (JP) | 2018-03-28 | — | — | EP | claimed |
| US-20160208311-A1 | METHOD FOR MEASURING CHOLESTEROL IN HIGH-DENSITY LIPOPROTEIN, AND REAGENT FOR USE IN SAID METHOD | SEKISUI MEDICAL CO., LTD. (JP) | 2016-07-21 | — | — | US | claimed |
| EP-3040421-A1 | METHOD FOR MEASURING CHOLESTEROL IN HIGH-DENSITY LIPOPROTEIN, AND REAGENT FOR USE IN SAID METHOD | Sekisui Medical Co., Ltd. (JP) | 2016-07-06 | — | — | EP | claimed |
| US-8623948-B2 | Polycarbonate compositions having antistatic enhancers, method of preparing, and articles comprising the same | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2014-01-07 | — | — | US | claimed |
| EP-1832574-B1 | Methods of making an antistatic agent | SABIC INNOVATIVE PLASTICS IP (NL) | 2011-08-10 | — | — | EP | claimed |
| EP-1737814-B1 | METHODS OF MAKING AN ANTISTATIC AGENT | SABIC INNOVATIVE PLASTICS IP (NL) | 2010-06-09 | — | — | EP | claimed |
| US-20090326116-A1 | POLYCARBONATE COMPOSITIONS HAVING ANTISTATIC ENHANCERS, METHOD OF PREPARING, AND ARTICLES COMPRISING THE SAME | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2009-12-31 | — | — | US | claimed |
| US-20080269526-A1 | METHODS OF MAKING AN ANTISTATIC AGENT | SAIC INNOVATIVE PLASTICS, IP B.V. (NL) | 2008-10-30 | — | — | US | claimed |
| JP-2008519077-A | — | — | 2008-06-05 | — | — | JP | claimed |
| US-20080015377-A1 | METHODS OF MAKING AN ANTISTATIC AGENT | GENERAL ELECTRIC COMPANY (US) | 2008-01-17 | — | — | US | claimed |
| WO-2005100307-A2 | METHODS OF MAKING AN ANTISTATIC AGENT | GENERAL ELECTRIC COMPANY (US) | 2005-10-27 | — | — | WO | claimed |
| US-20050228194-A1 | Methods of making an antistatic agent | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2005-10-13 | — | — | US | claimed |
| US-20050140047-A1 | Thermoplastic composition containing polymeric anti-static salt, method of making, and use thereof | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2005-06-30 | — | — | US | claimed |
| EP-1177256-B1 | COMPOSITIONS AND METHODS FOR REDUCED FOOD ADHESION | GEN ELECTRIC (US) | 2005-06-22 | — | — | EP | claimed |
| JP-2002543232-A | — | — | 2002-12-17 | — | — | JP | claimed |
| JP-2002542358-A | — | — | 2002-12-10 | — | — | JP | claimed |
| EP-1177256-A1 | COMPOSITIONS AND METHODS FOR REDUCED FOOD ADHESION | GENERAL ELECTRIC COMPANY (US) | 2002-02-06 | — | — | EP | claimed |
| EP-1173506-A1 | COMPOSITIONS AND METHODS FOR REDUCED FOOD ADHESION | GENERAL ELECTRIC COMPANY (US) | 2002-01-23 | — | — | EP | claimed |
| WO-2000064981-A1 | COMPOSITIONS AND METHODS FOR REDUCED FOOD ADHESION | GENERAL ELECTRIC COMPANY (US) | 2000-11-02 | — | — | WO | claimed |
| WO-2000063283-A1 | COMPOSITIONS AND METHODS FOR REDUCED FOOD ADHESION | GENERAL ELECTRIC COMPANY (US) | 2000-10-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080015377-A1 | METHODS OF MAKING AN ANTISTATIC AGENT | GPX1, GPX4, PRDX1 | OPRM1 274/4885SPHK1 770/4885LMNA 3968/4885 |
| US-20050228194-A1 | Methods of making an antistatic agent | MTX1, GPX4, CA2 | OPRM1 205/4885SPHK1 1138/4885LMNA 3742/4885 |
| US-20080269526-A1 | METHODS OF MAKING AN ANTISTATIC AGENT | PGM2, CA6, NHERF1 | OPRM1 42/4885SPHK1 653/4885LMNA 4473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.